239 related articles for article (PubMed ID: 8218990)
21. Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus superinfection.
Huo TI; Wu JC; Lai CR; Lu CL; Sheng WY; Lee SD
J Hepatol; 1996 Oct; 25(4):439-44. PubMed ID: 8912142
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review.
Baskiran A; Atay A; Baskiran DY; Akbulut S
J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis delta virus infection in different time periods in Japan.
Tamura I; Ichimura H; Koda T; Katayama S; Kurimura O; Kurimura T
J Gastroenterol Hepatol; 1990; 5(4):407-10. PubMed ID: 2129812
[TBL] [Abstract][Full Text] [Related]
24. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
[TBL] [Abstract][Full Text] [Related]
25. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
26. Delta superinfection in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma in a Sahelian area. Study of 112 cases versus 46 controls.
Cenac A; Develoux M; Lamothe F; Soubiran G; Vetter JM; Soumana I; Trepo C
Trans R Soc Trop Med Hyg; 1987; 81(6):994-7. PubMed ID: 2845609
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus infection in liver cirrhosis and hepatocellular carcinoma in Jakarta Indonesia.
Sulaiman HA
Gastroenterol Jpn; 1989 Aug; 24(4):434-41. PubMed ID: 2550307
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Fattovich G; Stroffolini T; Zagni I; Donato F
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
[TBL] [Abstract][Full Text] [Related]
30. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
Ji J; Sundquist K; Sundquist J
J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
[TBL] [Abstract][Full Text] [Related]
31. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).
Wranke A; Pinheiro Borzacov LM; Parana R; Lobato C; Hamid S; Ceausu E; Dalekos GN; Rizzetto M; Turcanu A; Niro GA; Lubna F; Abbas M; Ingiliz P; Buti M; Ferenci P; Vanwolleghem T; Hayden T; Dashdorj N; Motoc A; Cornberg M; Abbas Z; Yurdaydin C; Manns MP; Wedemeyer H; Hardtke S;
Liver Int; 2018 May; 38(5):842-850. PubMed ID: 28963781
[TBL] [Abstract][Full Text] [Related]
32. [The return of the hepatitis delta virus].
Zoutendijk R; de Jonge PJ; de Man RA
Ned Tijdschr Geneeskd; 2016; 160():D70. PubMed ID: 27405575
[TBL] [Abstract][Full Text] [Related]
33. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
34. [The seroepidemiological observation on hepatitis delta virus infection].
Zhao X
Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Aug; 11(4):202-4. PubMed ID: 2225001
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of a patient with hepatocellular carcinoma associated with triple hepatitis virus (HBV, HDV, HCV) infection.
Koda T; Tamura I; Ishikawa K
Kansenshogaku Zasshi; 1998 Nov; 72(11):1188-92. PubMed ID: 9884504
[TBL] [Abstract][Full Text] [Related]
36. Impact of chewing betel-nut (Areca catechu) on liver cirrhosis and hepatocellular carcinoma: a population-based study from an area with a high prevalence of hepatitis B and C infections.
Wu GH; Boucher BJ; Chiu YH; Liao CS; Chen TH
Public Health Nutr; 2009 Jan; 12(1):129-35. PubMed ID: 18410705
[TBL] [Abstract][Full Text] [Related]
37. Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders.
Baig S; Siddiqui AA; Ahmed WU; Qureshi H; Arif A
J Coll Physicians Surg Pak; 2009 Nov; 19(11):699-703. PubMed ID: 19889265
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection?
Abbas Z; Qureshi M; Hamid S; Jafri W
Saudi J Gastroenterol; 2012; 18(1):18-22. PubMed ID: 22249087
[TBL] [Abstract][Full Text] [Related]
39. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
